ABSTRACT We have described a heterogeneously processed glycoprotein with an apparent molecular weight of 55,000 (gp55) that is encoded by the Friend spleen focus-forming virus, an acute erythroleukemia virus [Dresler, S., Ruta, M., Murray, M.
lines of evidence suggest that a small proportion of the gp55 in infected cells is located on the surface membranes. First, different nonproducer cell lines infected with cloned Friend spleen focus-forming virus were efficiently killed in the presence of complement by cytotoxic antisera that react with gp55. Furthermore, a clone of cells selected for resistance to the cytotoxic antibody synthesized an altered intracellular form of gp55. This immunoselection procedure appears to also be useful for isolating glycoprotein mutants of other RNA tumor viruses. Analysis of cell surface proteins labeled with [125I] iodine supported the idea that gp55 occurs on the plasma membranes. However, the cell surface gp55 had more highly processed oligosaccharides than the majority of the gp55, which occurs within the infected cells. In addition, we have found that leukemia cells from mice infected with the erythroleukemic Rauscher virus complex contain a membrane glycoprotein that appears similar to the gp55 encoded by Friend spleen focus-forming virus. The encoding of similar glycoproteins by independently isolated acute erythroleukemia viruses suggests that these glycoproteins may be important in leukemogenesis.
The Friend (F) and Rauscher (R) strains of acute erythroleukemia virus consist of at least two components (1) (2) (3) (4) (5) . One is a replication-defective virus that is responsible for the rapid transformation of erythropoietic stem cells in vivo (1, 6, 7) or in cell culture (8, 9) . This component is called the spleen focus-forming virus (SFFV) because of its ability to induce discrete foci of transformed cells in the spleens of infected mice (1, 6, 7, 10) . The other component, called the lymphatic (murine) leukemia virus (MuLV), is a replication-competent helper virus that by itself causes lymphatic leukemia after a relatively long latent period (4) . Recently, cells infected with F-SFFV alone have been isolated (2, 3, 5, 11) . When superinfected with cloned MuLVs of different strains, they release virus that is capable of causing acute erythroleukemia.
Little is known about the mechanisms by which MuLVs cause leukemia. However, recent evidence suggests that genetic recombination within their envelope glycoprotein genes (env) may often be involved in the formation of highly leukemogenic MuLVs (12) (13) (14) (15) (16) (17) (18) (19) (20) . For example, the onset of spontaneous leukemia in AKR mice is associated with the formation of highly leukemogenic env gene recombinants between endogenously inherited nonleukemogenic ecotropic and xenotropic MuLVs (12, 13, 17, 21) . Similar env gene recombinants also form during the onset of overt leukemia in mice inoculated with F-MuLV (18, 19) . Such recombinant leukemogenic MuLVs also occur in preparations of Moloney MuLV (14) (15) (16) (17) . Consequently, it has been suggested that recombinant env genes or their encoded glycoproteins play a causal role in leukemogenesis (12, 13, 15, 17, 19) .
In view of the above evidence, it is interesting that F-SFFV may also be an env gene recombinant between F-MuLV and an endogenous xenotropic virus (11, 19, 20, 22 (5) . However, gp55 also has several structural and antigenic features that are absent from gp70 (5, 22, 23 10% complement-inactivated fetal calf serum and antibiotics.
Labeling and Extraction of Cells. Methods for labeling of cells with L-[a5S]methionine and for efficiently extracting the labeled proteins have been described (26) . Lactoperoxidasecatalyzed cell surface radioiodination with [125I]iodine was performed with cell suspensions at 250C as described by Vitetta et al. (27) . Fibroblast monolayers were also labeled by this method except that the phosphate-buffered saline was supplemented with anhydrous CaCl2 and MgCl2, both at 0.1 mg/ml, to prevent cell lifting. The latter salts were dissolved in water and added as a concentrated solution.
Immunoprecipitation Procedures. The antisera to gp70 have been described (26) . The monospecific goat antibody to F-MuLV gp7O was generously provided by J. Collins (Duke University, Durham, NC). The goat antiserum to R-MuLV gp70 reacts also with pi5E and was generously provided by J. Gruber (National Cancer Institute, National Institutes of Health). A rat antiserum specific to gp55 was prepared as recommended by Ruscetti et al. (23) by subcutaneous injection of NRK clone 1 cells into Osborne-Mendel rats. The resulting antiserum had the properties expected (23) and reacted with gp70s of the amphotropic MCF 247 and HIX viruses but not with ecotropic Friend or Rauscher virus gp70s. Immunoprecipitation was performed by using a modification (28) of the fixed Staphylococcus aureus (Pansorbin, Sigma) procedure described by Kessler (29) but omitting bovine serum albumin from the buffers. The radioactive cell extracts were preadsorbed with normal goat serum and Pansorbin to reduce nonspecific immunoprecipitation.
Electrophoresis. Polyacrylamide gels (10-20%) containing sodium dodecyl sulfate (NaDodSO4) were made with the Laemmli buffer system (30) . Two-dimensional isoelectric focusing/NaDodSO4 gel electrophoresis was performed by using the procedure of O'Farrell (31). Where indicated, samples were treated with neuraminidase (32) before electrofocusing. Antigen-antibody complexes were disrupted by incubating the samples in electrophoresis buffer at 100°C for 5-10 min. The bacteria were then pelleted by centrifugation and the supernatants were carefully removed. All gels were processed by fluorography (33) .
Immunoselection of Resistant Cell Lines. Fibroblasts that were either uninfected or infected with cloned F-MuLV or F-SFFV or with both viruses were plated into 25-cm2tissue culture flasks at 5 X 104 cells per flask and were allowed to grow at 37°C to 106 cells per flask (30% confluency). Approximately 24 hr before addition of antisera, 0.50 MCi of [14C]nicotinamide (Amersham-Searle; 1 Ci = 3.7 X 1010 becquerels) was added to each flask as described (34) . After this incorporation period, the monolayers were thoroughly washed with fresh medium containing 10% heat-inactivated fetal calf serum (560C for 30 min). Each flask was then given 1.1 ml of fresh culture medium, 0.10 ml of rabbit complement (GIBCO), and 3,ul of either goat antiserum made to F-MuLV gp7O or normal preimmune goat serum. The flasks were incubated at 250C for 20 hr. At intervals, cytotoxicity was measured by assaying the radioactivity released into 50 Ml of culture medium and by microscopic examination. Antibody-mediated cytotoxicity could be clearly seen by the retraction of cell processes followed by loss of refractility, condensation of nuclei, and loss of adherence to the substratum. The amount of radioactivity released was measured in comparison with the total amount of incorporated radioactivity that could be recovered by adding 0.1% NaDodSO4.
After 24 hr. cells resistant to the cytotoxic antiserum were allowed to recover and were replated into fresh culture medium. After five treatments with cytotoxic antiserum as described above, fully resistant cell cultures were obtained. Cells were then cloned from these resistant cultures by plating into wells of a microtiter test plate (5) .
RESULTS
Occurrence of gp55 on infected cell surfaces As shown in Fig. 1 (lane 1) , extracts of L-[3sS]methionine-labeled Friend erythroleukemia cells contained three prominent radioactive components that precipitated with monospecific antiserum made to the F-MuLV virion envelope glycoprotein. Two of these components, gp75 and gPr9oenv (the biosynthetic precursor of gp75 and piSE), have been well characterized and are known to be encoded by the F-MuLV genome (32, 35) . We have recently shown that the third prominent component, gp55, is encoded by the F-SFFV genome (5, 23 (Fig. 2) . Antiserum made to R-MuLV gp70 also specifically killed the F-SFFV-infected NRK cells. Simi- larly, SFFV-infected BALB/c fibroblasts were killed efficiently by the cytotoxic antisera. However, our SFFV-infected Sc-i fibroblasts were killed relatively poorly. Differences in killing efficiency might be caused by differences in either amount or accessibility of the plasma membrane gp55 (37) .
Processing of oligosaccharides continues throughout glycoprotein transit through the endoplasmic reticulum and Golgi apparatus, and fucose and sialic acid termini are added onto large complex oligosaccharides only during the final stages of this migratory process (38) (39) (40) . We have previously presented evidence that most of the cellular gp55 migrates as a single component in polyacrylamide gels in the presence of NaDod-S04 (e.g., Fig. 1 ) and appears to be a stable intracellular. constituent with neutral oligosaccharide moieties (5). However, we found that a few percent of the gp55 molecules are further glycosylated to form heterogeneously sialylated molecules having apparent Mr in the range of 58,000-68,000 (5). In Fig.  3 proteins from these clones were immunoprecipitated with an antiserum that reacts with both gp7O and pl5E. Fig. 4A shows an electrophoretic analysis of the env gene products that were-present in several of the resistant cell clones derived from the F-MuLV-infected NRK cell culture. Whereas the wild-type infected cell line contained gPr9OenV, gp7O, and piSE (lane 2), the resistant H4 cell line (lane 1) synthesized gPr90ent but lacked gp70 and p15E. Because the H4 cell line with antiserum made to R-MuLV gp70 and the immunoprecipitates were electrophoresed in 10-20% polyacrylamide gels containing 0.1% NaDodSO4. Gel A is an analysis of F-MuLV-infected cells, whereas gel B is an analysis of F-SFFV-infected cells. Lane 
DISCUSSION
We previously presented evidence that gp55 is heterogeneously processed in Friend erythroleukemia cells and that only a few percent (usually 2-5%) has a larger size with an apparent Mr of 58,000-68,000 (5) . In addition, the large material can be separated by isoelectric focusing into discrete components that appear to differ in sialic acid content and correspondingly in size (5) . On the other hand, the majority of the cellular gp55 is smaller and more basic and it appears to lack highly processed complex oligosaccharides and to be unaffected by neuraminidase treatment. In addition, the smaller gp55 is not simply a precursor of the larger material, because radioactivity in [s5S]methionine-labeled gp55 is not efficiently chased into the larger components during a prolonged chase with unlabeled methionine (5) .
The results presented here establish that some gp55 occurs on the surface membranes of SFFV-infected fibroblasts and erythroleukemia cells. However, the majority of the surface membrane gp55 is composed of the large Mr 58,000-68,000 material, which constitutes only a few percent of total cellular gp55. Therefore, only a small proportion of the total cellular gp55 molecules could occur on the surface membranes and the majority must accumulate in intracellular site(s). These results are consistent with other evidence that the subcellular localization of glycoproteins is related to the completeness of processing of their oligosaccharides (38) (39) (40) . We have recently learned that similar large forms of gp55 have been independently detected on cell surfaces by Ruscetti Fig. 4) strongly support the conclusions that gp55 occurs on the cellular plasma membrane and that at least one cellular gene is required for gPr9Oenv processing.
The presence of gp55 on the surface membranes of cells infected with F-SFFV is likely to be important in the host immune response to Friend virus. For example, it has been shown that mice inoculated with syngeneic F-SFFV-infected fibroblasts produce killer T lymphocytes that specifically recognize an SFFV-associated cell surface antigen (41) . Similarly, mice with the Fv-2T/T genotype may be resistant to SFFV pathogenesis by a mechanism that involves cellular immunity (10) .
A similar mechanism may be involved in the resistance of rats to SFFV replication or pathogenesis (4) . Presumably, these forms of resistance would depend upon cell surface gp55 antigens that are absent from F-MuLV gp70 (22) .
As 
